跳至主要内容
临床试验/NCT01965873
NCT01965873已完成4 期

Enteral Nutrition for Treatment of Acute Pancreatitis - a Prospective, Randomized Clinical Trial

University Hospital Rijeka0 个研究点目标入组 214 人开始时间: 2007年5月1日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
214
主要终点
SIRS (Systemic Inflammatory Response Syndrome)

研究概览

简要总结

The purpose of this prospective randomised clinical trial is to compare beneficial and harmful effects of the use enteral nutrition versus a nil-by-mouth and intravenous fluid replacement principle of treatment in patients with moderate to severe acute pancreatitis (AP).

The hypothesis:

  • enteral nutrition is no significantly better compared with the nil-by-mouth principle regarding mortality, incidence of local and systemic complications, length of hospital stay, and intensity of the inflammatory response in patients with moderate to severe AP
  • enteral nutrition has the same safety as nil-by-mouth principle in patients with moderate to severe AP

详细描述

Patients with first attack of AP irrespective of etiology will be enrolled in the study, if they are eligible according to the following criteria:

Inclusion criteria:

  • onset of symptoms consistent with AP within 72 hours before admission to the hospital
  • an 3-fold elevation of serum amylase or serum lipase over the upper limit of normal
  • APACHE II score 6 or more
  • a signed informed consent

Exclusion criteria:

  • patients < 18 years of age
  • pregnant and breastfeeding women

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • onset of symptoms consistent with AP within 72 hours before admission to the hospital
  • an 3-fold elevation of serum amylase or serum lipase over the upper limit of normal
  • APACHE II score 6 or more
  • a signed informed consent

排除标准

  • patients < 18 years of age
  • pregnant and breastfeeding women

结局指标

主要结局

SIRS (Systemic Inflammatory Response Syndrome)

时间窗: 4 weeks

次要结局

  • Length of hospital stay(4 weeks)
  • Inflammatory response (CRP on the first and third day)(First and third day of admission)
  • All-cause mortality(4 weeks)
  • Local complications (pancreatic necrosis, fluid collections, pseudocyst, abscess)(4 weeks)
  • Other infections(4 weeks)
  • Organ failure (cardiovascular, respiratory, renal)(4 weeks)
  • Local septic complications(4 weeks)
  • Adverse events(4 weeks)

研究者

发起方
University Hospital Rijeka
申办方类型
Other
责任方
Principal Investigator
主要研究者

Goran Poropat

Medical doctor

University Hospital Rijeka

相似试验